- Report
- August 2026
- 487 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 166 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 168 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 180 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 186 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 179 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 267 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- July 2026
- 180 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2026
- 180 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- March 2026
- 150 Pages
Global
From €3355EUR$3,750USD£2,869GBP
- Report
- May 2026
- 350 Pages
Global
From €4428EUR$4,949USD£3,787GBP
- Report
- July 2026
- 110 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- July 2026
- 189 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- April 2026
- 180 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- January 2026
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- October 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- October 2025
- 162 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- April 2026
- 135 Pages
Global
From €3500EUR$4,190USD£3,098GBP

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more